Pharmacometabonomics Technique to Identify Warfarin Response Using Nuclear Magnetic Resonance Spectroscopy

Bawadikji, Abdulkader Ahmad; Teh, Chin-Hoe; Kader, Muhamad Ali Bin Sheikh Abdul; Sulaiman, Syed Azhar Syed; Ibrahim, Baharudin

doi:10.2174/1389201018666171103141828

Cited by 5 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Despite the strong daily variability, the presence of an individual metabolomic phenotype, i.e. a chemical signature typical for each individual [18,19], which is stable over a long period of time [20,21], makes urine analysis extremely suitable as an approach to precision medicine with the possibility of monitoring and following individual variations during disease progression or in response to drug administration [22,23] or nutrition and lifestyle interventions [24]. Moreover, in the past years urinary metabolomics has contributed to the characterization of the metabolic signature of diseases for diagnostic and prognostic purposes and to the understanding of its biochemical cause [25][26][27][28].…”

Section: Urinementioning

confidence: 99%

Pre-analytical processes in medical diagnostics: New regulatory requirements and standards

et al. 2019

View full text Add to dashboard Cite

The EU Framework 7 project SPIDIA was the occasion for development of NMR approaches to evaluate the impact of different pre-analytical treatments on the quality of biological samples dedicated to metabolomics. Systematic simulation of different pre-analytical procedures was performed on urine and blood serum and plasma. Here we review the key aspects of these studies that have led to the development of CEN technical specifications, to be translated into ISO/IS in the course of the EU Horizon 2020 project SPIDIA4P. Inspired by the SPIDIA results, follow-up research was performed, extending the analysis to different sample types and to the different effects of long-term storage. The latter activity was in conjunction with the local European da Vinci Biobank. These results (which partially contributed to the ANNEX of CEN/TS 16945"MOLECULAR IN VITRO DIAGNOSTIC EXAMINATIONS -SPECIFICATIONS FOR PRE-EXAMINATION PROCESSES FOR METABOLOMICS IN URINE, VENOUS BLOOD SERUM AND PLASMA") are presented in detail.

show abstract